Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jelena Berendika"'
Autor:
Jelena Berendika, Saša Jungić, Biljana Tubić, Gordana Malčić Kecman, Ivanka Rakita, Zdenka Gojković, Milka Vještica, Gordan Nikić, Božana Babić
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 610-615 (2021)
Malignant salivary gland tumors form 11% of all head and neck tumors. Salivary duct carcinoma (SDC) of the parotid gland is an uncommon and highly aggressive tumor accounting for 2% of all salivary gland malignancies. The fourth edition of the WHO Cl
Externí odkaz:
https://doaj.org/article/7dfa51728e4e49a1b8aaf8afff4ca764
Autor:
Dejan Djokanovic, Zdenka Gojkovic, Sasa Jungic, Jelena Berendika, Radoslav Gajanin, Biljana Tubić, Ivanka Rakita, Milka Vjestica
Publikováno v:
Vojnosanitetski pregled. 79:796-804
Background/Aim. Standard treatment options for the first-line treatment of metastatic colorectal carcinoma (mCRC) are 5-fluorouracil, folinic acid, oxaliplatin (FOL-FOX4)/capecitabine (CapOx), plus bevacizumab (bev) and 5-fluorouracil, folinic acid a
Autor:
Sanja Petković, Stefan Petković, Ljiljana Tadić-Latinović, Jelena Berendika, Biljana Tubić, Saša Jungić
Publikováno v:
Scripta Medica. 53:165-169
A malignant peripheral nerve sheath tumour (MPNST) is a highly aggressive sarcoma. This disease develops in a number of people with neurofibromatosis type 1 (NF1), which is a common genetic disease. The paper presents a patient with typical manifesta
Autor:
Jelena Berendika, Saša Jungić, Biljana Tubić, Ivanka Rakita, Milka Vještica, Dejan Đokanović, Zdenka Gojković, Nikolina Mirčeta, Sanja Petković, Vanda Marković-Peković
Publikováno v:
Scripta Medica. 53:29-35
Background / Aim: Up until ten years ago stage four melanoma was considered a disease with extremely poor prognosis. Standard therapy during this period of time was dacarbazine chemotherapy. Patients with better performance status were treated with i
Autor:
Božana Babić, Milka Vjestica, Đokanović D, Savić S, Jelena Berendika, Zdenka Gojkovic, Gordan Nikic, Biljana Tubić, Sasa Jungic
Introduction: Mixed adenoneuroendocrine carcinoma (MANEC) is a tumor of the gastrointestinal tract that contains both exocrine and endocrine components, with each component representing a minimum of 30% of the total tumor mass.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dadf9e999c4576dda60ab1fbee5ca6d4
https://doi.org/10.22541/au.161531973.37978628/v1
https://doi.org/10.22541/au.161531973.37978628/v1
Autor:
Sasa Jungic, Zdenka Gojkovic, Ivanka Rakita, Dejan Djokanovic, Tamara Visekruna, Gordan Nikic, Milka Vjestica, Olja Jovic-Djokanovic, Jelena Berendika, Zoran Mavija
Publikováno v:
Vojnosanitetski Pregled, Vol 77, Iss 11, Pp 1235-1236 (2020)
nema